MacroGenics, Inc. Common Stock (NASDAQ: MGNX) last traded at $4.10, up 0.74% on the session. The quote above updates while this page is open; the figures below are drawn from MacroGenics, Inc. Common Stock’s own filings and are restated only when a new one is published.
MacroGenics, Inc. Common Stock trades on NASDAQ under the ticker MGNX. Its market capitalisation is $261.17 million.
Valuation measures for MacroGenics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $261.17M |
|---|---|
| Enterprise value | $449.80M |
| Price / sales | 1.56 |
| Price / book | 6.09 |
| Beta | 1.00 |
Trailing-twelve-month figures tagged in MacroGenics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $167.67M |
|---|---|
| Net income (TTM) | -$14.59M |
| EPS (TTM) | -$0.230 |
| Operating margin | -20.45% |
| Return on equity | -34.04% |
| Cash | $113.91M |
Range and volume for MGNX over the past 52 weeks.
| 52-week high | $5.08 |
|---|---|
| 52-week low | $1.29 |
| Volume | 253.6K |
| Average volume | 888.7K |
| Previous close | $4.07 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.